The role of biosimilars in the treatment of rheumatic diseases

Thomas Dörner; Vibeke Strand; Gilberto Castañeda-Hernández; Gianfranco Ferraccioli; John D Isaacs; Tore K Kvien; Emilio Martin-Mola; Thomas Mittendorf; Josef S Smolen; Gerd R Burmester

doi:10.1136/annrheumdis-2012-202715

Article info

PDF

Review

The role of biosimilars in the treatment of rheumatic diseases

Free

Authors

Thomas Dörner CC12 Department of Medicine, Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Berlin, GermanyDeutsches Rheumaforschungszentrum (DRFZ), Charité—University Medicine Berlin, Berlin, Germany PubMed articles Google scholar articles
Vibeke Strand Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA PubMed articles Google scholar articles
Gilberto Castañeda-Hernández Department of Pharmacology, Cinvestav, Mexico-City, Mexico PubMed articles Google scholar articles
Gianfranco Ferraccioli Rheumatology Division, Catholic University of the Sacred Heart, Rome, Italy PubMed articles Google scholar articles
John D Isaacs Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UKMusculoskeletal Directorate, Newcastle upon Tyne hospitals NHS Foundation Trust, Newcastle upon Tyne, UK PubMed articles Google scholar articles
Tore K Kvien Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway PubMed articles Google scholar articles
Emilio Martin-Mola Rheumatology Unit, La Paz University Hospital, Madrid, Spain PubMed articles Google scholar articles
Thomas Mittendorf Herescon GmbH, Hannover, Germany PubMed articles Google scholar articles
Josef S Smolen Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria PubMed articles Google scholar articles
Gerd R Burmester CC12 Department of Medicine, Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Berlin, Germany PubMed articles Google scholar articles

Correspondence to Professor Thomas Dörner, CC12 Department of Medicine, Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany;thomas.doerner{at}charite.de

View Full Text

Citation

Dörner T, Strand V, Castañeda-Hernández G, et al

The role of biosimilars in the treatment of rheumatic diseases

Annals of the Rheumatic Diseases 2013;72:322-328.

Publication history

Received September 21, 2012
Revised November 23, 2012
Accepted December 2, 2012
First published December 19, 2012.

Online issue publication

October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password